Purchase Order 75N93022P01224
Award Date 9/16/22
Potential Completion Date 5/31/25
Potential Value $936K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Montgomery Village, MD 20879, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc., on June 10, 2017, with a ceiling value of $804,692 for long-term stability testing of a nanoparticle-based HIV envelope-containing vaccine under NIAID preclinical development support. Place of performance is Rockville, Maryland. The order extends through June 9, 2029, and carries cost-plus-fixed-fee pricing with no set-aside designation. Government invoicing across...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order contract valued at $8.3 million to International AIDS Vaccine Initiative Inc. (IAVI) on September 26, 2023, for the manufacture of influenza virus human challenge material to support Phase I and II clinical testing. The contract utilizes a cost-plus-fixed-fee pricing structure and carries no set-aside designation. Work will be performed in Bowling Green, New York, with an ultimate completion date of...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Duke University on August 31, 2024, with a ceiling value of $5.885 million, for feasibility development of a liposome/LNP displaying an HIV Env trimer protein and containing/incorporating mRNA, and for preclinical and translational vaccine development support for HIV and other candidate agents. The order is issued under the parent indefinite delivery contract titled "Preclinical and Translational Vaccine...
- <p>The National Institute of Allergy and Infectious Diseases issued a delivery order to International AIDS Vaccine Initiative Inc. on September 19, 2017, with a ceiling value of $105,353.00 for product development plans to support HIV vaccine manufacturing efforts.</p> <p>Place of performance is New York, NY. The order is cost-plus-fixed-fee and was completed on September 19, 2018. No set-aside was used.</p>
- The National Institute of Allergy and Infectious Diseases issued a delivery order to International AIDS Vaccine Initiative Inc. on August 28, 2018, with a ceiling value of $26.065 million for manufacture of human flu challenge material. Work is performed in New York, NY under Cost Plus Fixed Fee pricing, with an ultimate completion date of May 14, 2028. The delivery order supports IAVI's vaccine development and manufacturing services, including process development, analytical testing, cGMP...
- This $8,398,301.00 cost-reimbursement delivery order was awarded on December 1, 2021 by the National Institute of Allergy and Infectious Diseases (NIAID) to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization. The award is part of NIAID's Preclinical And Translational Vaccine Development for HIV and Other Candidate Agents (PTVDS) program and will support IAVI's preclinical and translational vaccine development work for HIV and other infectious diseases through...
- <p>The National Institute of Allergy and Infectious Diseases issued a delivery order to International AIDS Vaccine Initiative Inc. on July 15, 2019, with a ceiling value of $3,170,861 for coordination and technical support in NIAID's process and analytical support program for HIV vaccine development.</p> <p>Place of performance is New York, NY. The order is priced on a cost-plus-fixed-fee basis with an ultimate completion date of July 14, 2020. No set-aside was used.</p>
- <p>The National Institute of Allergy and Infectious Diseases issued a delivery order to International AIDS Vaccine Initiative Inc. on September 20, 2016, with a ceiling value of $1.572 million for purification of HIV envelope proteins using an immunoaffinity-based process.</p> <p>Work is performed in New York, NY. The order was priced on a cost-plus-fixed-fee basis and carried an ultimate completion date of June 15, 2020. The award included de-obligation of remaining FY 2017 funds.</p>
- This federal contract award, valued at $1,707,175.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization. The contract supports process development for cell culture, upstream and downstream processes in the production of HIV-1 biomolecules, as part of NIAID's broader program for process and analytical support in the...
- This is a $1,327,640.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization. The contract is for "COORDINATION AND TECHNICAL SUPPORT" under NIAID's program for "PROCESS AND ANALYTICAL SUPPORT FOR DEVELOPMENT OF HIV VACCINES". IAVI, as the prime contractor, will provide a...